Royalty Report: Cannabis, Drugs, Therapeutic – Collection: 278523

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 13

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 13

Primary Industries

  • Cannabis
  • Drugs
  • Therapeutic
  • Beverages
  • Cancer
  • Disease
  • Pain
  • Food
  • Consumer Goods
  • Retail & Leisure
  • Personal Care
  • Beauty Aid
  • Pharmaceuticals
  • Veterinary
  • Tobacco
  • Medical
  • Healthcare

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 278523

License Grant
Under the terms of the agreement, the parties will develop a new product utilizing the intellectual property of Licensor and the launch of the co-branded product.
License Property
The focus is on the development, sale and distribution of hemp oil-based products that contain naturally occurring cannabinoids, including cannabidiol ('CBD') and other products containing CBD-rich hemp oil (“Legal Hemp”).
Field of Use
This agreement pertains to the cannabis industry.

IPSCIO Record ID: 264659

License Grant
Licensee, a shareholder,  has a non-exclusive right to sell Prana Hemp in certain situations where the sale is to be completed through the use of a credit card associated with a merchant account owned and/or controlled by Licensee.
License Property
The intellectual property we licensed includes know-how relating to the design and buildout of cultivation facilities, growing/cultivation systems, seed-to-sale protocols and procedures, products, access to a genetic catalogue including over 150 different strains, an advanced (non-psychoactive) cannabinoid sequencing therapy program utilizing patent-pending Prana Bio Nutrient Medicinals called the A.C.T. Now Program (“ACT Now” or “ACT Now Program”), security, regulatory compliance, and other methods and processes which relate to the cannabis industry.

Licensor is a biotech company focused on developing targeted therapeutics for the prevention of the negative side effects of chemotherapy, management of rheumatoid arthritis and treatment of brain cancer. The focus is on extracting products from industrial hemp plants, which the Licensor wholesale to manufacturers, and which are used to create unique therapeutics for a wide range of diseases that can be utilized by patients globally. Licensor own distinct intellectual property relating to the legalized growth, production, manufacture, marketing, management, utilization and distribution of medical and recreational marijuana and marijuana infused products.

Field of Use
This agreement pertains to the drug industry.  The intellectual property is licensed to businesses in the cannabis industry.

IPSCIO Record ID: 229839

License Grant
The Licensor grants to Licensee, a non-exclusive limited License for the right to utilize the Property solely in connection with the legal branding of the Licensed Articles and the marketing, sale and distribution of said THC branded products containing cannabis and nationwide for Pineapple Express branded products containing CBD rich hemp oil, in the specific Territory and Retail Channels via print and digital catalog and online marketing via THC.com, Pineapple Express.com, and other marketing platforms solely paid for by Licensee.  Products are any and all licensed products manufactured using cannabis infused oils, tinctures, butters, for topical and ingestible use.
License Property
Licensor has created and owns and/or controls the Property.

Property includes any and all licensed products manufactured using cannabis infused oils, tinctures, butters, for topical and ingestible use.

Field of Use
Licensee desires to obtain a License to manufacture certain items of merchandise or products bearing or otherwise utilizing the Property and to seek Licensors help to market, sell and distribute said Licensed Articles within the Territory.

IPSCIO Record ID: 195184

License Grant
Licensor, the largest shareholder of Licensee, grants to Licensee a License under the Licensed Technology, to sell, re-sell, offer for sale, import, put into use, as applicable, the Licensed Materials.  Licensed Materials A propriety organic set of products made with European Cannabidiol extracted from legal industrial hemp, limited to the Doc Rico product line.
License Property
The Licensor has developed and owns certain trade secrets and technology for the Industrial Hemp industry made with European Cannabidiol that is extracted from Legal Industrial Hemp.  Product line includes
Doc Rico Topical CBD & Frankincense Pain Relief Balm
Doc Rico Detoxifying Charcoal Lavender Face & Body Soap
Doc Rico Detoxifying Charcoal Patchouli Face & Body Soap
Doc Rico Relaxing Lavender Mint Aromatherapy Lip Balm Doc Rico Rich Hemp Oil w/Full Spectrum CBD, Citrus Flavor
Doc Rico Hand & Body Lotion
Field of Use
The Licensee obtains rights to use the Licensed Technology for commercial purposes related to the Industrial Hemp Industry. The field of use shall consist of the Doc Rico product line which contain less than 0.3 percent THC.

IPSCIO Record ID: 249613

License Grant
The Canadian Licensor and Licensee have agreed to collaborate to develop and manufacture a line of at least 3 co-branded topical cosmetic products formulated with a cannabinoid or cannabinoids.
License Property
Cannabis is a plant used in products for medical proposes.
Field of Use
This agreement pertains to the drug industry relating to cannabis.

IPSCIO Record ID: 263711

License Grant
The subsidiary will assume the manufacturing, sale and distribution of the pet supplement business and manage the production facility in Washington State from the Canadian Parent.  The net operating profit and loss sharing arrangement was terminated.
License Property
The business is in the technology of tissue culture science and to provide the highest quality 100% germ free, disease free and all genetically the same plantlets of high CBD hemp and other flora and offering full spectrum DNA testing for plant identification, live genetics preservation using  low temperature storage for various cannabis and horticulture plants; extraction of botanical oils mainly CBD oil, and to deliver laboratory based services to the North American high CBD hemp, Cannabis and agriculture sectors.
Field of Use
This agreement pertains to the drug industry.

IPSCIO Record ID: 266631

License Grant
Licensor hereby grants to Licensee an exclusive, world-wide, License to use the HDI Technology solely in the Cannabis Application, for the purpose of processing Cannabis Materials using the SPR in the Cannabis Industry. (The aforesaid license grant is herein sometimes referred to as the “License”).

Licensor grants an exclusive license to all Licensors Intellectual Property and patented technology and creates a partnership to bring their patented controlled cavitation process to the cannabis industry.

License Property
Licensor has the Shockwave Powerâ„¢ Reactor (SPR) rights for mixing and Heating, Hydrogenating Substances, Continuous Hydrodynamics cavitation crystallization, and four other patents.

Licensor is the owner of certain Technology called ShockWave Power™. Licensor owns Intellectual Property (“IP”, defined below), manifested in Patents, Trade Secrets, and Know How, which are embodied in Licensor's proprietary ShockWave Power Reactor/Extractor (“SPR™), and which IP is useful in a variety of industries including but not limited to those industries that extract, mix, heat, hydrate, homogenize and crystallize materials.

“Cannabis Industry” means the industry where cannabis oils and other compounds containing cannabis (“Cannabis Materials”, defined below) are derived from the cannabis sativa, cannabis indica, and cannabis ruderalis plants, including marijuana and hemp, either singularly or by mixing with substances other than cannabis oils.

“Cannabis Application” means the use of the Licensor Technology to achieve a specific result when processing only “Cannabis Materials”.

“ShockWave Power Reactor/Xtractor (SPR™”) means HDI’s proprietary device that embodies the HDI Technology in performing multiple heating, mixing and extraction functions.

“ShockWave Power Reactor/Xtractor (SPR™”) means HDI’s proprietary device that embodies the HDI Technology in performing multiple heating, mixing and extraction functions.

“Standalone SPR” means an SPR mounted on a skid containing no other equipment other than that necessary to run the SPR.

Field of Use
Illustrative, but not all, areas of use of the Licensed Technology covered by this Agreement are
(i) UV light for decarboxylation of THC
(ii) Crystallization of CBD or THC
(iii) mixing of cannabis oil with other substances to create foods, beverages, or other products which are themselves not cannabis oils
(iv) Use of Electrochemistry or UltraViolate (UV) SPR’s or other advanced oxidation materials to produce radicals for the production of CBN
(v) Hydrogenation of cannabis oils
(vi) processing of hemp oils for biofuels.
(vii) Development of an SPR for supercritical CO2

IPSCIO Record ID: 301640

License Grant
Sublicensor hereby grants to Sublicensee, and Sublicensee hereby accepts, a transferable, non-exclusive right and license under the Licensed Science to make or have made the Licensed Products and to use the Licenses Science Patents, Know-How, and Licensed Products in connection with the Field, including the distribution, sale, and marketing thereof, in the Territory.

The Licensed Science Sublicense granted is for the purpose of engaging in the business of treating, producing, manufacturing, marketing and selling Licensed Products.

License Property
Licensed Products means any CBD products related to the Field, whether owned by Licensor or Sublicensor or licensed by Licensor or Sublicensor now or hereafter, that are covered by any Valid Claim(s) contained in any of the Patents, and/or based on the products, processes or methods developed using the Licensed Science.

The Licensed Science as its relates to the production, methods, and products of CBD and its derivatives.

Field of Use
Field means the
(a) production and manufacturing of CBD, CBD byproducts and CBD derivatives, from non-psychoactive, low-THC cannabis sativa plant strains and cannabinoids (collectively, Cannabis), for Sale and use at retail or wholesale where permitted, including, without limitation, CBD food additives, CBD edibles, and CBD hemp variations of the foregoing;
(b) CBD-related research, teaching and education for both medical and other purposes; and
(c) all medical uses and applications of CDB.

The Field is exclusive to production, methods, and products of CBD and its derivatives, and excludes and prohibits any THC related products having measurable tetrahydrocannabinol concentration potency above 3.0% on a dry weight basis, production methods, techniques, or Know How.

IPSCIO Record ID: 279986

License Grant
Licensor grants an exclusive, world-wide license to the Legal use of the Licensor Technology solely for the Technology Application.
License Property
Licensor has certain intellectual property relating to oil separation technology called Density Segregation Technology, which is manifested in Patents, Trade Secrets, and Know How, which are embodied in Licensor proprietary intellectual property.

Density Segregation Technology or DST means Licensor’s proprietary devices that embodies the Licensor Technology in performing multiple separation and extraction functions.

Plant Materials means cannabis plants.

The patents are titled Method and Device for Separating a Lighter Density Fluid from a Heavier Density Fluid, and, Method and Device for Removing Bubbles from Liquid.

Field of Use
Licensee field of use is to recover Legal cannabidiol (CBD) oil and other Legal extracts from Plant Materials.

IPSCIO Record ID: 365842

License Grant
The Parties hereby agree to form a Delaware Limited Liability Company to pursue the Business Opportunities and developing additional markets for the sale of the Products in various states in the United States of America. Licensor will provide the undisclosed New Company with devices specifically configured for hemp/CBD and the New Company will have the exclusive right to that configuration in the defined geographic area. Licensor will design and build the equipment necessary for the manufacturing of the Consumables and contribute that equipment to New Company. Licensor will license its intellectual property to the New Company as necessary.
License Property
Licenors Technology means the developed and patented “heat not burn” technology which allows hemp/CBD to be ingested via inhalation without the necessity of burning the organic product technology and patents include an activator device that provides the heat (“Device”) and consumable packets containing a susceptor as the heating element and the hemp/CBD to be heated (“Consumables”).
Field of Use
Field of use is for creating hemp/CBD to be ingested via inhalation.

IPSCIO Record ID: 307318

License Grant
Licensor hereby grants Canadian Licensee an exclusive, sublicensable, non-transferable, non-assignable right and license to use and practice Licensor Intellectual Property Rights related to the Commercialization of the Cannabis Products and the CBD Products, and which are listed (the Defined Intellectual Property Rights) for Commercializing the Branded Products in the Territory (the License).
License Property
All Intellectual Property Rights related to the trademarks High Times and Culture.

All know-how, methods, trade secrets and other Confidential Information held by Licensor and protected by HT Intellectual Property.

All proprietary formulations for manufacturing cannabis extracts, edible cannabis and other Cannabis Products held by Licensor and protected by HT Intellectual Property.

All proprietary methods of cultivation, processing and other aspects of supply chain management owned by Licensor held by Licensor and protected by HT Intellectual Property.

“HT Technology” means know-how, methods, trade secrets and other Confidential Information held by Licensor and protected by HT Intellectual Property Rights, including formulations for manufacturing cannabis extracts, edible cannabis and other Cannabis Products and including methods cultivation, processing and other supply chain management.

Products means Cannabis Products or CBD Products.

High Times may be applied to Cannabis Products.

Culture, or upon Parties’ agreement, a new mark in substitution or in addition to Culture, may be applied to CBD Products.

Cannabis Product means Cannabis Inputs and Other Inputs that have been prepared, packaged and labelled as a consumer packaged good for sale to a consumer at the retail level.

Cannabis Input means any cannabis flowers, leaves, extract, synthesized phytocannabinoids or other cannabis used with the Other Inputs in the manufacture of a Cannabis Product.

Branded Products means any Products that carry the Licensor Branding.

CBD Product means CBD Inputs and Other Inputs that have been prepared, packaged and labelled for as a consumer packaged good for sale to a consumer at the retail level.

CBD Input means cannabidiol or cannabidiolic acid inputs that are from any flowers, leaves, extract or other sources of cannabidiol or cannabidiolic acid that are sourced from industrial hemp plants and that are not sourced from cannabis plants that are prohibited by federal law. The CBD Input is used with the Other Inputs in the manufacture of a CBD Product.

Branding means all trademarks, trade dress, trade and business names, brand names, logos, design rights, corporate names and domain names and other similar designations of source, sponsorship, association or origin, together with the goodwill symbolized by any of the foregoing, which are developed, licensed or otherwise accessed by Licensee for branding and promoting the Branded Products.

Licensor Technology means know-how, methods, trade secrets and other Confidential Information held by Licensor and protected by HT Intellectual Property Rights, including formulations for manufacturing cannabis extracts, edible cannabis and other Cannabis Products and including methods cultivation, processing and other supply chain management.

Intellectual Property Rights means all industrial and other intellectual property rights comprising or relating to (a) Branding; (b) internet domain names, whether or not Branding, registered by any authorized private registrar or Governmental Authority, web addresses, web pages, website and URLs; (c) works of authorship, expressions, designs and industrial design registrations, whether or not copyrightable, including copyrights and copyrightable works, software and firmware, data, data files, and databases and other specifications and documentation; (d) inventions, discoveries, trade secrets, business and technical information, know-how, databases, data collections, patent disclosures and other confidential or proprietary information; (e) plant varieties, strains or cultivars; and (f) all industrial and other intellectual property rights, and all rights, interests and protections that are associated with, equivalent or similar to, or required for the exercise of, any of the foregoing, however arising, in each case whether registered or unregistered, such registered rights including patent, registered plant breeders’ rights, trademark, industrial design, copyright, Plant Varieties Protection Act registrations and including all registrations and applications for, and renewals or extensions of, such rights or forms of protection under the Applicable Law of any jurisdiction in any part of the world.

Field of Use
Licensee is in the business of Commercializing the Cannabis Products through licensed cannabis dispensaries and various other channels.

The Licensee has been the worlds most recognized and trusted cannabis brand – championing the lifestyle and educating the masses on the benefits of this natural flower.  Licensee is engaged in the publication of a monthly print and on-line magazine and the production and sponsorship of trade shows and events. The strategic goal is to monetize the intellectual property and “High Times®” brand. The Licensee also contemplates various other e-commerce initiatives and licensing of the “High Times®” brand, including the development of an e-commerce store offering clothing and other products associated with cannabis.

IPSCIO Record ID: 359060

License Grant
The Parties entered into a sponsored research agreement to conduct research and development efforts relating to Licensors COVID-19 and rheumatoid arthritis (RA) product candidates. The focused is on characterizing the activity of cannabinoids in RA and in hyperinflammatory syndrome related to COVID-19.

In accordance with the terms of the Research Agreement, Israelis Licensee and Israelis Licensor will have joint ownership of any IP created as a result of research programs covered by such agreement. In connection with the Research Agreement, Licensor agreed not to work, study or develop any technologies with other entities that compete with our work with Licensor for our COVID-19 product candidate or RA product candidate for a term of three and seven years, respectively, from the end of the parties’ collaboration with respect to the COVID-19 product candidate and seven years from the end of the term of the Research Agreement with respect to the RA product candidate.

License Property
Cannabidiol, or CBD, oil is derived from CBD strains with low levels of Tetrahydrocannabinol, or THC. The discovery platform currently focuses the use of CBD oil, one of the cannabinoids in cannabis plants, as the active pharmaceutical ingredient, or API, for our RA product candidate and COVID-19 product candidate.

The Licensor  have been conducting research on the use of cannabis to treat disorders with widespread inflammatory responses, such as RA and COVID-19. Parties hope that by decoding the cannabinoid mechanism of action during inflammatory storms, the Parties can treat inflammation associated with COVID-19 where conventional drugs and other therapies have failed.

Field of Use
Field of use is for the treatment in RA and in hyperinflammatory syndrome related to COVID-19.

Rheumatoid arthritis (RA) is a long-term autoimmune disorder. COVID-19 is a virus infection.

IPSCIO Record ID: 249612

License Grant
The Canadian Licensor and Canadian Licensee have agreed to collaborate to develop and manufacture a line of at least 3 co-branded topical cosmetic products formulated with a cannabinoid or cannabinoids.
License Property
Cannabis is a plant used in products for medical proposes.
Field of Use
This agreement pertains to the drug industry relating to cosmetic products.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.